Recombinant Deoxyribonucleic Acid (rDNA) Technology - Global Market Outlook (2020-2028)

Global Recombinant Deoxyribonucleic Acid (rDNA) Technology Market is accounted for $141.76 billion in 2020 and is expected to reach $301.68 billion by 2028 growing at a CAGR of 9.9% during the forecast period. Some of the key factors propelling the market growth include increasing demand for recombinant and genetically modified products for human health, food and agriculture, increasing government funding regarding the use of recombinant DNA technology to solve the various food, healthcare and environmental issues, technological advancements in genomics, and expansion of biopharmaceutical industry. However, ethical challenges associated with gene therapy and stringent regulations for approval of the product are restricting the market growth.

Recombinant DNA technology involves the insertion of DNA fragments having a desirable gene sequence in a vector molecule. The technology is exploited for producing various human proteins such as hormones, enzymes, cytokines, and monoclonal antibodies in microorganisms. Recombinant DNA technology joints together DNA molecules from two various species which is then inserted into the host organism to produce a new genetic combination having a wide application in medicine, agriculture, and industry. Basic tools required in recombinant DNA technology include the enzymes, the vectors and host organism. It is widely used in manufacturing of medicine, gene therapy, and clinical diagnosis.

By component, the expression system segment is expected to grow at the significant rate throughout the forecast period, due to the ongoing developments for efficient protein expression and for its further isolation on a large scale. Majorly used expression systems are mammalian, bacterial, insects, and yeast. The development of cell lines such as HEK293 and Chinese Hamster Ovarian (CHO) has contributed to the significant share of mammalian expression systems. In addition, ongoing research studies to explore the potential of plant as expression system are expected to drive the adoption of plan expression systems for GM product development in the coming years.

On the basis of geography, Asia Pacific region is expected to witness a rapid growth rate over the forecast period. Countries such as India and China are expected to support the growth of Asia Pacific owing to the increasing government funding for research and development. Moreover, conducting clinical trials in Asian countries such as India are relatively less costly in comparison with the western countries. This has resulted in the migration of several global biopharmaceutical developers towards this region. Furthermore, Japan is recognized as one of the world’s largest per capita importers of food and feed developed using modern biotechnology tools. Japan’s regulatory system for GE crops continues to improve.

Some of the key players in Recombinant Deoxyribonucleic Acid (rDNA) Technology Market include Pfizer Inc., Novartis AG, Eli Lilly and Company, GlaxoSmithKline plc., Novo Nordisk A/S, Monsanto Company, F. Hoffmann-La Roche Ltd, Amgen Inc., Sanofi SA, Merck KGaA, Biogen Inc., Profacgen, Horizon Discovery Group plc, Genscript Biotech, Biocon Limited, Boehringer Ingelheim, Thermo Fisher Scientific, Inc., and Chiron Corporation.

Components Covered:
• Cloning Vector
• Expression System

Products Covered:
• Non-Medical
• Medical

Applications Covered:
• Environment
• Food & Beverages
• Diagnostics
• Research
• Healthcare & Disease
• Therapeutics
• Agriculture

End Users Covered:
• Academic & Government Research Institutes
• Biotechnology and Pharmaceutical Companies
• Diagnostic Laboratories
• Biochemical Industry

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK 
o Spain
o Rest of Europe      
• Asia Pacific
o Japan       
o China       
o India       
o Australia       
o New Zealand
o South Korea   
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2019, 2020, 2021, 2025 and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter’s five forces analysis, SWOT analysis, etc.
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

 

1 Executive Summary      
       
2 Preface      
 2.1 Abstract     
 2.2 Stake Holders     
 2.3 Research Scope     
 2.4 Research Methodology     
  2.4.1 Data Mining    
  2.4.2 Data Analysis    
  2.4.3 Data Validation    
  2.4.4 Research Approach    
 2.5 Research Sources     
  2.5.1 Primary Research Sources     
  2.5.2 Secondary Research Sources    
  2.5.3 Assumptions    
       
3 Market Trend Analysis      
 3.1 Introduction     
 3.2 Drivers     
 3.3 Restraints     
 3.4 Opportunities     
 3.5 Threats     
 3.6 Product Analysis     
 3.7 Application Analysis     
 3.8 End User Analysis     
 3.9 Emerging Markets     
 3.10 Impact of Covid-19     
       
4 Porters Five Force Analysis      
 4.1 Bargaining power of suppliers     
 4.2 Bargaining power of buyers     
 4.3 Threat of substitutes     
 4.4 Threat of new entrants     
 4.5 Competitive rivalry     
       
5 Global Recombinant Deoxyribonucleic Acid (rDNA) Technology Market, By Component      
 5.1 Introduction     
 5.2 Cloning Vector     
  5.2.1 Cosmid    
  5.2.2 Human Artificial Chromosome (HAC)    
  5.2.3 Plasmid    
  5.2.4 Yeast Artificial Chromosome (YAC)    
  5.2.5 Phage    
  5.2.6 Bacterial Artificial Chromosome (BAC)    
 5.3 Expression System     
  5.3.1 Bacteria    
  5.3.2 Baculovirus / Insect     
  5.3.3 Mammalian Cells    
  5.3.4 Yeast    
  5.3.5 Prokaryotic Cells    
       
6 Global Recombinant Deoxyribonucleic Acid (rDNA) Technology Market, By Product      
 6.1 Introduction     
 6.2 Non-Medical     
  6.2.1 Specialty Chemicals     
  6.2.2 Biotech Crops    
  6.2.3 Genetically Modified Crops    
 6.3 Medical     
  6.3.1 Human Protein    
  6.3.2 Therapeutic Agent    
  6.3.3 Vaccine    
  6.3.4 Gene Editing    
  6.3.5 Recombinant Protein Drugs    
   6.3.5.1 Interferon    
   6.3.5.2 Blood Factors   
   6.3.5.3 Insulin   
   6.3.5.4 Fusion Proteins   
   6.3.5.5 Human Growth Hormone   
   6.3.5.6 Colony Stimulating Factors   
   6.3.5.7 Erythropoietin   
  6.3.6 Cell and Gene Therapy    
  6.3.7 Monoclonal Antibodies    
       
7 Global Recombinant Deoxyribonucleic Acid (rDNA) Technology Market, By Application      
 7.1 Introduction     
 7.2 Environment     
 7.3 Food & Beverages     
 7.4 Diagnostics     
 7.5 Research     
 7.6 Healthcare & Disease     
  7.6.1 Animal    
  7.6.2 Human    
 7.7 Therapeutics     
 7.8 Agriculture     
       
8 Global Recombinant Deoxyribonucleic Acid (rDNA) Technology Market, By End User      
 8.1 Introduction     
 8.2 Academic & Government Research Institutes      
 8.3 Biotechnology and Pharmaceutical Companies     
 8.4 Diagnostic Laboratories     
 8.5 Biochemical Industry     
       
9 Global Recombinant Deoxyribonucleic Acid (rDNA) Technology Market, By Geography      
 9.1 Introduction     
 9.2 North America     
  9.2.1 US    
  9.2.2 Canada    
  9.2.3 Mexico    
 9.3 Europe     
  9.3.1 Germany    
  9.3.2 UK    
  9.3.3 Italy    
  9.3.4 France    
  9.3.5 Spain    
  9.3.6 Rest of Europe    
 9.4 Asia Pacific     
  9.4.1 Japan    
  9.4.2 China    
  9.4.3 India    
  9.4.4 Australia    
  9.4.5 New Zealand    
  9.4.6 South Korea    
  9.4.7 Rest of Asia Pacific    
 9.5 South America     
  9.5.1 Argentina    
  9.5.2 Brazil    
  9.5.3 Chile    
  9.5.4 Rest of South America    
 9.6 Middle East & Africa     
  9.6.1 Saudi Arabia    
  9.6.2 UAE    
  9.6.3 Qatar    
  9.6.4 South Africa    
  9.6.5 Rest of Middle East & Africa    
       
10 Key Developments      
 10.1 Agreements, Partnerships, Collaborations and Joint Ventures     
 10.2 Acquisitions & Mergers     
 10.3 New Product Launch     
 10.4 Expansions     
 10.5 Other Key Strategies     
       
11 Company Profiling      
 11.1 Pfizer Inc.     
 11.2 Novartis AG     
 11.3 Eli Lilly and Company     
 11.4 GlaxoSmithKline plc.     
 11.5 Novo Nordisk A/S     
 11.6 Monsanto Company     
 11.7 F. Hoffmann-La Roche Ltd     
 11.8 Amgen Inc.     
 11.9 Sanofi SA     
 11.10 Merck KGaA     
 11.11 Biogen Inc.     
 11.12 Profacgen     
 11.13 Horizon Discovery Group plc     
 11.14 Genscript Biotech     
 11.15 Biocon Limited     
 11.16 Boehringer Ingelheim     
 11.17 Thermo Fisher Scientific, Inc.     
 11.18 Chiron Corporation     

 

Recombinant Deoxyribonucleic Acid (rDNA) Technology - Global Market Outlook (2020-2028)

List of Tables       
1 Global Recombinant Deoxyribonucleic Acid (rDNA) Technology Market Outlook, By Region (2019-2028) ($MN)      
2 Global Recombinant Deoxyribonucleic Acid (rDNA) Technology Market Outlook, By Component (2019-2028) ($MN)      
3 Global Recombinant Deoxyribonucleic Acid (rDNA) Technology Market Outlook, By Cloning Vector (2019-2028) ($MN)      
4 Global Recombinant Deoxyribonucleic Acid (rDNA) Technology Market Outlook, By Cosmid (2019-2028) ($MN)      
5 Global Recombinant Deoxyribonucleic Acid (rDNA) Technology Market Outlook, By Human Artificial Chromosome (HAC) (2019-2028) ($MN)      
6 Global Recombinant Deoxyribonucleic Acid (rDNA) Technology Market Outlook, By Plasmid (2019-2028) ($MN)      
7 Global Recombinant Deoxyribonucleic Acid (rDNA) Technology Market Outlook, By Yeast Artificial Chromosome (YAC) (2019-2028) ($MN)      
8 Global Recombinant Deoxyribonucleic Acid (rDNA) Technology Market Outlook, By Phage (2019-2028) ($MN)      
9 Global Recombinant Deoxyribonucleic Acid (rDNA) Technology Market Outlook, By Bacterial Artificial Chromosome (BAC) (2019-2028) ($MN)      
10 Global Recombinant Deoxyribonucleic Acid (rDNA) Technology Market Outlook, By Expression System (2019-2028) ($MN)      
11 Global Recombinant Deoxyribonucleic Acid (rDNA) Technology Market Outlook, By Bacteria (2019-2028) ($MN)      
12 Global Recombinant Deoxyribonucleic Acid (rDNA) Technology Market Outlook, By Baculovirus / Insect (2019-2028) ($MN)      
13 Global Recombinant Deoxyribonucleic Acid (rDNA) Technology Market Outlook, By Mammalian Cells (2019-2028) ($MN)      
14 Global Recombinant Deoxyribonucleic Acid (rDNA) Technology Market Outlook, By Yeast (2019-2028) ($MN)      
15 Global Recombinant Deoxyribonucleic Acid (rDNA) Technology Market Outlook, By Prokaryotic Cells (2019-2028) ($MN)      
16 Global Recombinant Deoxyribonucleic Acid (rDNA) Technology Market Outlook, By Product (2019-2028) ($MN)      
17 Global Recombinant Deoxyribonucleic Acid (rDNA) Technology Market Outlook, By Non-Medical (2019-2028) ($MN)      
18 Global Recombinant Deoxyribonucleic Acid (rDNA) Technology Market Outlook, By Specialty Chemicals (2019-2028) ($MN)      
19 Global Recombinant Deoxyribonucleic Acid (rDNA) Technology Market Outlook, By Biotech Crops (2019-2028) ($MN)      
20 Global Recombinant Deoxyribonucleic Acid (rDNA) Technology Market Outlook, By Genetically Modified Crops (2019-2028) ($MN)      
21 Global Recombinant Deoxyribonucleic Acid (rDNA) Technology Market Outlook, By Medical (2019-2028) ($MN)      
22 Global Recombinant Deoxyribonucleic Acid (rDNA) Technology Market Outlook, By Human Protein (2019-2028) ($MN)      
23 Global Recombinant Deoxyribonucleic Acid (rDNA) Technology Market Outlook, By Therapeutic Agent (2019-2028) ($MN)      
24 Global Recombinant Deoxyribonucleic Acid (rDNA) Technology Market Outlook, By Vaccine (2019-2028) ($MN)      
25 Global Recombinant Deoxyribonucleic Acid (rDNA) Technology Market Outlook, By Gene Editing (2019-2028) ($MN)      
26 Global Recombinant Deoxyribonucleic Acid (rDNA) Technology Market Outlook, By Recombinant Protein Drugs (2019-2028) ($MN)      
27 Global Recombinant Deoxyribonucleic Acid (rDNA) Technology Market Outlook, By Cell and Gene Therapy (2019-2028) ($MN)      
28 Global Recombinant Deoxyribonucleic Acid (rDNA) Technology Market Outlook, By Monoclonal Antibodies (2019-2028) ($MN)      
29 Global Recombinant Deoxyribonucleic Acid (rDNA) Technology Market Outlook, By Application (2019-2028) ($MN)      
30 Global Recombinant Deoxyribonucleic Acid (rDNA) Technology Market Outlook, By Environment (2019-2028) ($MN)      
31 Global Recombinant Deoxyribonucleic Acid (rDNA) Technology Market Outlook, By Food & Beverages (2019-2028) ($MN)      
32 Global Recombinant Deoxyribonucleic Acid (rDNA) Technology Market Outlook, By Diagnostics (2019-2028) ($MN)      
33 Global Recombinant Deoxyribonucleic Acid (rDNA) Technology Market Outlook, By Research (2019-2028) ($MN)      
34 Global Recombinant Deoxyribonucleic Acid (rDNA) Technology Market Outlook, By Healthcare & Disease (2019-2028) ($MN)      
35 Global Recombinant Deoxyribonucleic Acid (rDNA) Technology Market Outlook, By Animal (2019-2028) ($MN)      
36 Global Recombinant Deoxyribonucleic Acid (rDNA) Technology Market Outlook, By Human (2019-2028) ($MN)      
37 Global Recombinant Deoxyribonucleic Acid (rDNA) Technology Market Outlook, By Therapeutics (2019-2028) ($MN)      
38 Global Recombinant Deoxyribonucleic Acid (rDNA) Technology Market Outlook, By Agriculture (2019-2028) ($MN)      
39 Global Recombinant Deoxyribonucleic Acid (rDNA) Technology Market Outlook, By End User (2019-2028) ($MN)      
40 Global Recombinant Deoxyribonucleic Acid (rDNA) Technology Market Outlook, By Academic & Government Research Institutes (2019-2028) ($MN)      
41 Global Recombinant Deoxyribonucleic Acid (rDNA) Technology Market Outlook, By Biotechnology and Pharmaceutical Companies (2019-2028) ($MN)      
42 Global Recombinant Deoxyribonucleic Acid (rDNA) Technology Market Outlook, By Diagnostic Laboratories (2019-2028) ($MN)       
43 Global Recombinant Deoxyribonucleic Acid (rDNA) Technology Market Outlook, By Biochemical Industry (2019-2028) ($MN)      
       

 

.